Evidence map›Paper›PMID 40544187›Full record

ArticleScientific data2025

STInt: An integrated dataset covering science, technology and industry information in the pharmaceutical field.

Shuo Xu, Zhen Liu, Xin An

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shuo XuBeijing University of Technology, Beijing, 100124, P.R. China.
Zhen LiuBeijing University of Technology, Beijing, 100124, P.R. China.
Xin AnBeijing Forestry University, Beijing, 100083, P.R. China. anxin@bjfu.edu.cn.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 72004012National Natural Science Foundation of China (National Science Foundation of China) 72074014
6 · The paper itself

Abstract

With the rapid development of the economy, the linkages among science, technology, and industry have become increasingly close, and more and more study focus on the binary or ternary interactions among the three. However, the different datasets and fields used in previous studies make it difficult to directly compare and synthesize research results. This further affects the comprehensive understanding of the binary and ternary interactions among science, technology, and industry. Therefore, this paper constructs a multi-source integrated dataset covering science, technology, and industry information based on the DrugBank database. Our dataset is named as STInt (Science-Technology-Industry interactions), which covers document entities, researcher entities, organization entities, and classification entities, and contains rich semantic relationships among them. In addition, STInt is freely available at Figshare, and stored as a MySQL database and make it openly available on GitHub. Our STInt dataset will be useful for conducting research on the binary or ternary linkages among science, technology, and industry, and for gaining a deeper understanding of the developmental patterns in the pharmaceutical field.

Indexed as

Databases, FactualDrug IndustryScienceTechnology

Identifiers

PMID40544187
PMCPMC12182565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.